Reed Smith LLP
We are only able to display limited information for this firm. We display more complete information for all of the following firms:
Reed Smith LLP advises life sciences clients on FDA regulatory matters and broader regulatory issues arising in complex transactions. The firm provides guidance on regulatory strategy and market entry for companies developing healthcare technologies. Scot Hasselman, co-chair of the life sciences health industry group and based in Washington, DC, advises healthcare companies and investors on regulatory, transactional, and litigation matters. In New York, Cori Annapolen Goldberg focuses on FDA regulatory issues affecting food, drug, dietary supplement, biologic, medical device, and HCT/P industries across the supply chain.
Legal 500 Editorial commentary
Testimonials
Collated independently by Legal 500 research team.
‘They are extremely practical and understand the business of our company well.’
‘Very good healthcare life sciences practice at Reed Smith; we enjoy working with them.’